Breaking Down Huangshan Novel Co.,Ltd Financial Health: Key Insights for Investors

Investors seeking a clear snapshot of Huangshan Novel Co., Ltd. will want to note the latest quarter's top-line surge to CNY 959.89 million (up 8.02% QoQ) and a trailing twelve months revenue of CNY 3.69 billion (YoY growth 7.35%), underpinned by 2,366 employees and revenue per employee of ~CNY 1.56 million; profitability shows a robust net income of CNY 472.11 million (net margin 12.79%) and an efficient ROE of 18.87%, while valuation and shareholder returns are reflected in a market cap of CNY 6.90 billion, P/E of 15.65, P/S of 1.87 and a 4.71% dividend yield-financial strength is further evidenced by a net cash position (CNY 1.11 billion cash vs CNY 922.7 million debt), operating cash flow of CNY 461.5 million covering CNY 152 million capex, and a conservative 40.0% debt-to-equity ratio-read on for the full breakdown of liquidity, solvency, valuation and the key risks and growth opportunities shaping the stock's outlook

Huangshan Novel Co.,Ltd (002014.SZ) - Revenue Analysis

• Quarter (ending 2025-09-30) revenue: CNY 959.89 million, +8.02% vs. prior quarter.
• Trailing Twelve Months (TTM) revenue: CNY 3.69 billion, +7.35% year-over-year.
• Full-year 2024 revenue: CNY 3.53 billion, +4.34% vs. 2023.
• Revenue per employee: ≈ CNY 1.56 million (2,366 employees).
• Price-to-Sales (P/S) ratio: 1.87.
• Market capitalization: CNY 6.90 billion.

• Quarterly momentum: an 8.02% sequential gain suggests accelerating demand or seasonal pickup in the most recent quarter.
• YTD/TTM growth: 7.35% TTM expansion outpaces 2024 full-year growth (4.34%), indicating improving top-line traction across the past 12 months.
• Productivity and scale: revenue per employee (~CNY 1.56M) provides a benchmark for operational efficiency versus peers in the sector.
• Valuation context: a P/S of 1.87 with CNY 6.90B market cap implies investors are valuing future growth moderately above one year of sales.

Huangshan Novel Co.,Ltd (002014.SZ) - Profitability Metrics

• Net income (TTM): CNY 472.11 million
• Net profit margin (TTM): 12.79%
• Gross margin (TTM): 22.71%
• Return on equity (ROE): 18.87%
• Earnings per share (EPS): CNY 0.76
• Price-to-earnings (P/E) ratio: 15.65
• Dividend yield: 4.71% (ex-dividend date: September 30, 2025)

• Drivers of profitability: solid gross margin (22.71%) indicating product/service pricing over COGS, efficient capital use reflected in ROE (18.87%), and consistent net conversion to profit (12.79%).
• Investor considerations: P/E 15.65 implies valuation relative to earnings; dividend yield 4.71% provides income appeal but requires monitoring of payout sustainability and ex-dividend timing (2025-09-30).
• Operational focus areas: preserving gross margin through cost control, sustaining ROE via prudent leverage and asset efficiency, and protecting net margin from margin compression.

Huangshan Novel Co.,Ltd (002014.SZ) - Debt vs. Equity Structure

• Debt-to-equity ratio: 40.0% - indicates moderate leverage relative to shareholder equity.
• Net cash position: Cash & equivalents CNY 1.11 billion vs. total debt CNY 922.7 million - the company holds more cash than debt.
• Operating cash flow: CNY 461.5 million - robust operational cash generation.
• Capital expenditures: CNY 152 million - comfortably covered by operating cash flow.
• Financial risk: Low - conservative approach to borrowing and ample liquidity buffer.
• Reinvestment & returns: Positive OCF minus CapEx suggests internal funds are available for growth initiatives and shareholder distributions.

Huangshan Novel Co.,Ltd (002014.SZ) - Liquidity and Solvency

• Operating cash flow (most recent): CNY 461.5 million
• Net cash position: Positive (net cash)
• Current ratio: Not specified, but implied strong by net cash position
• Quick ratio: Not specified, cash and equivalents imply good short-term health
• CapEx coverage: Operating cash flow sufficient to cover capital expenditures
• Capital structure: Conservative; low financial leverage

Huangshan Novel Co.,Ltd (002014.SZ) - Valuation Analysis

Huangshan Novel Co.,Ltd (002014.SZ) presents a valuation profile consistent with a mature, dividend-paying mid-cap in its sector. Key market-implied metrics point to a balance between earnings-based valuation, revenue multiple, and income return to shareholders.

• P/E ratio: 15.65 - reflects the market's willingness to pay CNY 15.65 for CNY 1 of reported earnings.
• P/S ratio: 1.87 - indicates the market values the company at 1.87 times its annual revenue.
• Dividend yield: 4.71% - provides a meaningful cash return relative to share price, attractive for income-focused investors.
• Market capitalization: CNY 6.90 billion - positions the company in the small-to-mid cap segment, with liquidity and scale considerations for investors.

• Relative valuation: The company's P/E and P/S sit in line with industry standards, suggesting a fair market valuation rather than a discount or premium extreme.
• Earnings support: Positive financial performance and consistent dividends underpin these valuation levels, lowering downside risk from valuation compression.
• Investor considerations: The 4.71% yield can offset modest multiple contraction and appeals to income-oriented investors; total return prospects depend on earnings growth and margin stability.

For context on the company's broader strategic framing and values, see: Mission Statement, Vision, & Core Values (2026) of Huangshan Novel Co.,Ltd.

Huangshan Novel Co.,Ltd (002014.SZ) - Risk Factors

Huangshan Novel operates in a capital- and commodity-sensitive packaging industry. The company's financial health is exposed to multiple risks that can meaningfully affect revenue, margins and cash flow. Below are the principal risk vectors with quantified sensitivity where possible, and practical indicators investors should monitor.

• Raw material price volatility: paper pulp, corrugate, adhesives and coatings are primary cost drivers. A sustained 10% rise in paper/pulp prices can erode gross margin by ~2-4 percentage points depending on product mix and hedging effectiveness.
• Economic cyclicality and demand risk: exposure to downstream customers (food, consumer goods, e-commerce logistics). A 5-10% GDP slowdown in key end markets historically correlates with a comparable decline in order volumes for packaging suppliers.
• Foreign exchange exposure: export sales and imported raw materials create FX P&L and translation risk. A 5% depreciation of the RMB versus major trading currencies can reduce reported net profit by an estimated 1-3% if not hedged.
• Regulatory and compliance costs: changes in environmental rules, recycling mandates or packaging restrictions can raise capex and operating costs. New pollutant control or recycling targets can increase compliance-related capital spending by tens to hundreds of millions RMB depending on plant upgrades.
• Competitive pricing pressure: intense competition from regional peers and large integrated players can compress selling prices. Price competition of 3-7% can reduce EBITDA margins materially if input costs cannot be passed through.
• Supply chain and logistics disruptions: raw material shortages, transport bottlenecks or plant downtime can delay deliveries and trigger penalty clauses. A single major supply interruption lasting weeks can reduce monthly revenue by double-digit percent for affected facilities.

Operational and financial scenarios below illustrate how these risks map to key financial metrics under plausible shock cases.

• How the company mitigates these risks: inventory strategy and raw-material hedging, diversified customer base across FMCG and e-commerce, incremental automation to reduce unit costs, and investments in environmental controls to meet regulatory standards.
• What investors should monitor: raw material price indices (pulp/paper), order book and utilization rates, FX hedging disclosures, capex guidance and environmental compliance spending, quarterly gross margin trends, and working capital days.

For corporate context and strategic orientation that affect how Huangshan Novel prioritizes these risks, see: Mission Statement, Vision, & Core Values (2026) of Huangshan Novel Co.,Ltd.

Huangshan Novel Co.,Ltd (002014.SZ) - Growth Opportunities

Huangshan Novel Co.,Ltd (002014.SZ) can capitalize on multiple growth vectors to improve top-line expansion and margin resilience. The following sections outline tangible initiatives, estimated impacts, and operational levers.

• Geographic expansion into Southeast Asia: ASEAN packaging demand is expanding with an estimated CAGR of 5-7% (2023-2028). Entering key markets such as Vietnam, Indonesia and Thailand could unlock incremental revenue equal to 8-15% of current domestic sales within 3-5 years, assuming targeted distribution and localized product adaptation.
• Enhancing distribution networks: Doubling regional distributors and adding 2-3 centralized logistics hubs can reduce lead times by 20-40% and lower logistics costs by 5-8% of sales, improving service levels for fast-moving FMCG clients.
• New product lines - functional packaging: Introducing barrier films, recyclable laminates and active packaging can command ASP premiums of 10-30% versus basic packaging and diversify revenue toward higher-margin segments (gross-margin lift of 3-6 percentage points).
• Strategic technology partnerships: Collaborations with automation and digital-printing firms can improve production throughput by 15-30% and reduce variable labor cost by up to 10% over 24 months.
• R&D investment: Targeting R&D spend of 1.5-3.0% of revenue (vs. typical 0.5-1.5% in traditional packaging) can accelerate proprietary material development and shorten time-to-market for premium products.
• Brand building: Focused brand and account-based marketing in food, pharma and personal care channels can increase repeat purchase rates and lift market share in targeted segments by 3-7 percentage points over 2-4 years.

Prioritization should consider payback period, balance-sheet capacity and existing manufacturing utilization. For a detailed corporate background and historical context, see: Huangshan Novel Co.,Ltd: History, Ownership, Mission, How It Works & Makes Money